Cargando…
Cytomegalovirus infection after renal transplantation
Renal transplant patients show a high prevalence of cytomegalovirus (CMV) infection after the procedure. This study was conducted to assess the prevalence and factors associated with the incidence of CMV infection among renal transplant patients. A total of 100 patients were recruited in this study....
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852648/ https://www.ncbi.nlm.nih.gov/pubmed/35186139 http://dx.doi.org/10.25122/jml-2021-0209 |
_version_ | 1784653083463122944 |
---|---|
author | Al Atbee, Mohammed Younus Naji Tuama, Hala Sami |
author_facet | Al Atbee, Mohammed Younus Naji Tuama, Hala Sami |
author_sort | Al Atbee, Mohammed Younus Naji |
collection | PubMed |
description | Renal transplant patients show a high prevalence of cytomegalovirus (CMV) infection after the procedure. This study was conducted to assess the prevalence and factors associated with the incidence of CMV infection among renal transplant patients. A total of 100 patients were recruited in this study. The CMV load in the blood of each patient was assessed using the technique of polymerase chain reaction (PCR). The serostatus of all recipients and donors was examined preoperatively and those of the recipients again postoperatively. The association of CMV load was assessed with the following factors: age, gender, alanine aminotransferase (ALT) and serum creatinine levels, types of immunosuppressive and induction regimens, preoperative diabetes status, and serological virologic response (SVR) at 12 weeks postoperatively. Our findings showed that CMV incidence was significantly higher in middle-aged patients (62 of 66 patients, 93.9%; p=0.0001). Furthermore, about 88.2% of patients induced by anti-thymocyte globulin (ATG) showed a high viral load, significantly higher than the proportion of CMV-positive patients induced by basiliximab (p=0.001). In addition, a higher proportion of CMV-negative recipients who received the graft from CMV-positive donors and vice-versa were CMV-positive postoperatively. Administration of Valcyte 450 showed 100% efficiency in decreasing the CMV load in the patients. Among all the assessed factors, only the age of the recipients, type of induction therapy used, and the preoperative serostatus of both donors and recipients were significantly associated with the postoperative CMV incidence among the patients. |
format | Online Article Text |
id | pubmed-8852648 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Carol Davila University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-88526482022-03-01 Cytomegalovirus infection after renal transplantation Al Atbee, Mohammed Younus Naji Tuama, Hala Sami J Med Life Original Article Renal transplant patients show a high prevalence of cytomegalovirus (CMV) infection after the procedure. This study was conducted to assess the prevalence and factors associated with the incidence of CMV infection among renal transplant patients. A total of 100 patients were recruited in this study. The CMV load in the blood of each patient was assessed using the technique of polymerase chain reaction (PCR). The serostatus of all recipients and donors was examined preoperatively and those of the recipients again postoperatively. The association of CMV load was assessed with the following factors: age, gender, alanine aminotransferase (ALT) and serum creatinine levels, types of immunosuppressive and induction regimens, preoperative diabetes status, and serological virologic response (SVR) at 12 weeks postoperatively. Our findings showed that CMV incidence was significantly higher in middle-aged patients (62 of 66 patients, 93.9%; p=0.0001). Furthermore, about 88.2% of patients induced by anti-thymocyte globulin (ATG) showed a high viral load, significantly higher than the proportion of CMV-positive patients induced by basiliximab (p=0.001). In addition, a higher proportion of CMV-negative recipients who received the graft from CMV-positive donors and vice-versa were CMV-positive postoperatively. Administration of Valcyte 450 showed 100% efficiency in decreasing the CMV load in the patients. Among all the assessed factors, only the age of the recipients, type of induction therapy used, and the preoperative serostatus of both donors and recipients were significantly associated with the postoperative CMV incidence among the patients. Carol Davila University Press 2022-01 /pmc/articles/PMC8852648/ /pubmed/35186139 http://dx.doi.org/10.25122/jml-2021-0209 Text en ©2022 JOURNAL of MEDICINE and LIFE https://creativecommons.org/licenses/by/3.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Original Article Al Atbee, Mohammed Younus Naji Tuama, Hala Sami Cytomegalovirus infection after renal transplantation |
title | Cytomegalovirus infection after renal transplantation |
title_full | Cytomegalovirus infection after renal transplantation |
title_fullStr | Cytomegalovirus infection after renal transplantation |
title_full_unstemmed | Cytomegalovirus infection after renal transplantation |
title_short | Cytomegalovirus infection after renal transplantation |
title_sort | cytomegalovirus infection after renal transplantation |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852648/ https://www.ncbi.nlm.nih.gov/pubmed/35186139 http://dx.doi.org/10.25122/jml-2021-0209 |
work_keys_str_mv | AT alatbeemohammedyounusnaji cytomegalovirusinfectionafterrenaltransplantation AT tuamahalasami cytomegalovirusinfectionafterrenaltransplantation |